Edward C. Franklin

This article is about the American immunologist. For the chemist, see Edward Curtis Franklin.

Edward Claus Franklin (April 14, 1928 – February 20, 1982) was a pioneering American immunologist and physician. He made major gains in the study of the aging process with contributions that led to the discovery of a group of abnormal protein aggregates known as amyloids, and played a key role in the fight against Arthritis, Alzheimer's disease, Parkinson's disease, Huntington's disease, Diabetes, and Cardiac arrhythmia.[1] Franklin was a professor of medicine at the New York University School of Medicine,[2] a member of the National Academy of Sciences,[3] president of the American Society for Clinical Investigation,[2] and director of Irvington House Institute.[3] The New York Times called Franklin "an international authority on the human immune system".[2]

Franklin discovered heavy chain disease, one type of which is named after him (Franklin's disease).[2][3] The Edward C. Franklin Award, which is given for achievements in immunology, has been established in his name.[4][5]

  1. ^ Chiti, Fabrizio; Dobson, Christopher M. (2017-06-20). "Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade". Annual Review of Biochemistry. 86: 27–68. doi:10.1146/annurev-biochem-061516-045115. hdl:2158/1117236. ISSN 1545-4509. PMID 28498720.
  2. ^ a b c d Waggoner, Walter H. (1982-02-25). "DR. EDWARD C. FRANKLIN DIES; HUMAN-IMMUNOLOGY PIONEER". The New York Times. ISSN 0362-4331. Retrieved 2021-12-09.
  3. ^ a b c Read "Biographical Memoirs: Volume 78" at NAP.edu. National Academies Press. 2000. doi:10.17226/9977. ISBN 978-0-309-07035-5.
  4. ^ "Distinguished Service Award". 1983 IEEE MTT-S International Microwave Symposium Digest. IEEE. 1983. p. 16. doi:10.1109/mwsym.1983.1131006.
  5. ^ Weissmann, Gerald (August 1982). "Edward C. Franklin 1928–1982". Arthritis & Rheumatism. 25 (8): 1029. doi:10.1002/art.1780250826.